10c target in 12 month

http://www.imugene.com/uploads/2/0/2/0/20208565/130507_research_report_imugene_final.pdf

"Action and Recommendation - Speculative BUY. We believe Imugene? efficient business model is misunderstood by investors and we see multiple opportunities for value creation. We expect increased appreciation of the company? platform and portfolio over the next 12 months as management continues to execute on Linguet?commercialization strategy. We view Imugene as significantly undervalued relative to its peer group."

Looks like 0.007c bottom been confirmed now, SP should take off and back to 1.4c soon.

"Vitamin D development program at commercialisation stage"

I believe IMU will release the agreement soon, hopefully Vitamin D can generate $1-2m initial cash flow for IMU"

If only IMU can receive $3m+ per year from Vitamin business alone, IMU will be worth more than 10c per share.

Current MC is 2m only, dirty cheap!